Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis

PurposeThe aim of the present study was to describe the purchasing patterns of a set of antibiotics used exclusively in an out-patient pediatric setting in Italy using the Farma360 wholesale drug database (IQVIA Solutions Italy), identifying the proportion of medications which are not captured by It...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ: Janet Sultana, Gianluca Trifirò, Valentina Ientile, Andrea Fontana, Francesco Rossi, Annalisa Capuano, Carmen Ferrajolo
Ձևաչափ: Հոդված
Լեզու:English
Հրապարակվել է: Frontiers Media S.A. 2020-08-01
Շարք:Frontiers in Pharmacology
Խորագրեր:
Առցանց հասանելիություն:https://www.frontiersin.org/article/10.3389/fphar.2020.01232/full
_version_ 1828341225940320256
author Janet Sultana
Gianluca Trifirò
Valentina Ientile
Andrea Fontana
Francesco Rossi
Francesco Rossi
Annalisa Capuano
Annalisa Capuano
Carmen Ferrajolo
Carmen Ferrajolo
author_facet Janet Sultana
Gianluca Trifirò
Valentina Ientile
Andrea Fontana
Francesco Rossi
Francesco Rossi
Annalisa Capuano
Annalisa Capuano
Carmen Ferrajolo
Carmen Ferrajolo
author_sort Janet Sultana
collection DOAJ
description PurposeThe aim of the present study was to describe the purchasing patterns of a set of antibiotics used exclusively in an out-patient pediatric setting in Italy using the Farma360 wholesale drug database (IQVIA Solutions Italy), identifying the proportion of medications which are not captured by Italian National Health Service (NHS) pharmacy claims databases and examining the implications of such findings from a public health and pharmaceutical policy perspective.MethodsUsing a systematic approach, sixty-six antibiotic pediatric formulations were selected for the 5 most commonly used antibiotics in Italy in children and adolescents: amoxicillin in combination with clavulanic acid, amoxicillin, azithromycin, clarithromycin and cefixime. The Farma360 wholesale drug purchasing database was used to identify the yearly proportion of antibiotics not purchased based on NHS reimbursement in primary care from 2015–2017 at the national level. The relationship between product cost and purchase outside the NHS was assessed by a scatterplot. All analyses were stratified by geographic area: Northwest, Northeast, Central and Southern Italy.ResultsThe proportion of antibiotics not reimbursed by the NHS increased nationally from 24% in 2015 to 29% in 2017. The antibiotic with the highest proportion of purchases outside the NHS was amoxicillin, with almost two-thirds of all amoxicillin purchases in Southern Italy being made in this way in 2017. The relationship between antibiotic price and antibiotic purchase outside the NHS was almost linear for many geographic areas.ConclusionsThis study showed that a large proportion of antibiotics with a pediatric formulation is purchased outside the NHS drug purchasing pathway, especially in Southern Italy, indicating that it is not possible to fully monitor drug utilization, including appropriateness, for these antibiotics. A better strategy is needed to improve drug utilization monitoring, such as better data collection or data linkage.
first_indexed 2024-04-13T23:10:42Z
format Article
id doaj.art-4c53b51a377f400f9d0113df13d6562b
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T23:10:42Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-4c53b51a377f400f9d0113df13d6562b2022-12-22T02:25:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-08-011110.3389/fphar.2020.01232551846Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization AnalysisJanet Sultana0Gianluca Trifirò1Valentina Ientile2Andrea Fontana3Francesco Rossi4Francesco Rossi5Annalisa Capuano6Annalisa Capuano7Carmen Ferrajolo8Carmen Ferrajolo9Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, ItalyDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, ItalyDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, ItalyIstituti di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo, ItalyDepartment of Clinical and Experimental Medicine, University of Campania “L. Vanvitelli”, Naples, ItalyCampania Regional Centre for Pharmacovigilance, Naples, ItalyDepartment of Clinical and Experimental Medicine, University of Campania “L. Vanvitelli”, Naples, ItalyCampania Regional Centre for Pharmacovigilance, Naples, ItalyDepartment of Clinical and Experimental Medicine, University of Campania “L. Vanvitelli”, Naples, ItalyCampania Regional Centre for Pharmacovigilance, Naples, ItalyPurposeThe aim of the present study was to describe the purchasing patterns of a set of antibiotics used exclusively in an out-patient pediatric setting in Italy using the Farma360 wholesale drug database (IQVIA Solutions Italy), identifying the proportion of medications which are not captured by Italian National Health Service (NHS) pharmacy claims databases and examining the implications of such findings from a public health and pharmaceutical policy perspective.MethodsUsing a systematic approach, sixty-six antibiotic pediatric formulations were selected for the 5 most commonly used antibiotics in Italy in children and adolescents: amoxicillin in combination with clavulanic acid, amoxicillin, azithromycin, clarithromycin and cefixime. The Farma360 wholesale drug purchasing database was used to identify the yearly proportion of antibiotics not purchased based on NHS reimbursement in primary care from 2015–2017 at the national level. The relationship between product cost and purchase outside the NHS was assessed by a scatterplot. All analyses were stratified by geographic area: Northwest, Northeast, Central and Southern Italy.ResultsThe proportion of antibiotics not reimbursed by the NHS increased nationally from 24% in 2015 to 29% in 2017. The antibiotic with the highest proportion of purchases outside the NHS was amoxicillin, with almost two-thirds of all amoxicillin purchases in Southern Italy being made in this way in 2017. The relationship between antibiotic price and antibiotic purchase outside the NHS was almost linear for many geographic areas.ConclusionsThis study showed that a large proportion of antibiotics with a pediatric formulation is purchased outside the NHS drug purchasing pathway, especially in Southern Italy, indicating that it is not possible to fully monitor drug utilization, including appropriateness, for these antibiotics. A better strategy is needed to improve drug utilization monitoring, such as better data collection or data linkage.https://www.frontiersin.org/article/10.3389/fphar.2020.01232/fullantibioticspediatricself-medicationobservational studyItaly
spellingShingle Janet Sultana
Gianluca Trifirò
Valentina Ientile
Andrea Fontana
Francesco Rossi
Francesco Rossi
Annalisa Capuano
Annalisa Capuano
Carmen Ferrajolo
Carmen Ferrajolo
Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
Frontiers in Pharmacology
antibiotics
pediatric
self-medication
observational study
Italy
title Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
title_full Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
title_fullStr Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
title_full_unstemmed Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
title_short Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis
title_sort traceability of pediatric antibiotic purchasing pathways in italy a nationwide real world drug utilization analysis
topic antibiotics
pediatric
self-medication
observational study
Italy
url https://www.frontiersin.org/article/10.3389/fphar.2020.01232/full
work_keys_str_mv AT janetsultana traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT gianlucatrifiro traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT valentinaientile traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT andreafontana traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT francescorossi traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT francescorossi traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT annalisacapuano traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT annalisacapuano traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT carmenferrajolo traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis
AT carmenferrajolo traceabilityofpediatricantibioticpurchasingpathwaysinitalyanationwiderealworlddrugutilizationanalysis